Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "Malova" Ovarian Cancer Study.

Anticancer research - 1 Jan 2000

Høgdall Estrid V, Kjaer Susanne K, Glud Eva, Christensen Lise, Blaakaer Jan, Vuust Jens, Bock Johannes E, Norgaard-Pedersen Bent, Hogdall Claus K

Abstract excerpt

BACKGROUND: The p53 gene is frequently mutated in various human tumours. In addition, single nucleotide polymorphisms are often observed in exons and introns of the p53 gene in normal tissues and tumours. MATERIALS AND METHODS: A total of 210 blood and tissue samples from 182 ovarian cancers (OC) and 28 ovarian borderline tumours, in addition to blood samples from 72 healthy women, were analysed. The used...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CA-125 Antigen
Share to Contraceptives, Oral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, p53

Share to Lectins, C-Type

Share to Neoplasm Staging

Share to Ovarian Neoplasms

Share to Polymorphism, Single-Stranded Conformational

Share to Smoking

Source

Identifiers

PMID: 12926080

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "Malova" Ovarian Cancer Study.PMID 12926080Read ↗

Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients.Semantic proximity Read ↗

Polymorphisms of the p53 gene in women with ovarian or endometrial carcinoma.Semantic proximity Read ↗

Mutation analysis of p53 in ovarian tumors by DHPLC.Semantic proximity Read ↗

[Both somatic and germline genetics of the TP53-pathway influence ovarian cancer incidence and survival].Semantic proximity Read ↗

Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations.Semantic proximity Read ↗

Genetic alterations in chromosome 10q24.3 and glutathione S-transferase omega 2 gene polymorphism in ovarian cancer.Semantic proximity Read ↗

TP53 gene status and human papilloma virus infection in response to platinum plus taxane-based chemotherapy of epithelial ovarian carcinomas.Semantic proximity Read ↗

The influence of HER2 genotypes as molecular markers in ovarian cancer outcome.Semantic proximity Read ↗

TP53 and P21 polymorphisms: response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer.Semantic proximity Read ↗

A polymorphism in intron 2 of the TP53 gene.Semantic proximity Read ↗

[Mutations of p53 gene exons 5 to 8 in human ovarian cancer and its clinical significance].Semantic proximity Read ↗

Exon 8-9 mutations of DNA polymerase β in ovarian carcinoma patients from Haldia, India.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.